Glaxo shares fall on UK probe

Comment on this story
GlaxoSmithKlinePharma REUTERS

London - Shares fell by more than 1 per cent, or 23 pence (0.38 dollars) to 1611.5 pence, in GlaxoSmithKline on Wednesday, after Britain's Serious Fraud Office (SFO) announced it was investigating it.

The London-based pharmaceutical giant has recently been accused by authorities in China, Iraq and Poland of bribing doctors to use its products in preference to others.

Two weeks ago Chinese police charged three of the company's top executives in China with bribery.

The SFO said on Tuesday it had launched a “criminal investigation into the commercial practices of GlaxoSmithKline and its subsidiaries,” adding that whistleblowers were “valuable sources of information” for it.

“We welcome approaches from anyone with inside information on all our cases including this one,” it said.

In a statement, Glazo said it was “committed to operating its business to the highest ethical standards” and that it would “continue to cooperate fully with the SFO.”

Under Britain's 2010 Bribery Act it is illegal for companies based there to bribe government employees, including doctors, at home and abroad. - Sapa-dpa

sign up

Comment Guidelines

  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines